| Dr Jerry M Obritsch, MD | |
|
1000 E Rosser Ave, Bismarck, ND 58501-4414 | |
| (701) 712-4500 | |
| (701) 712-4098 |
| Full Name | Dr Jerry M Obritsch |
|---|---|
| Gender | Male |
| Speciality | Obstetrics/gynecology |
| Experience | 37 Years |
| Location | 1000 E Rosser Ave, Bismarck, North Dakota |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093769291 | NPI | - | NPPES |
| 16790 | Medicaid | ND | |
| 160018356 | Other | ND | MEDICARE RAILROAD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 5899 (North Dakota) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Chi St Alexius Health | Bismarck, ND | Hospital |
| Mobridge Regional Hospital - Cah | Mobridge, SD | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Innovis Health Llc | 9931298155 | 473 |
| Mobridge Regional Hospital | 6507776135 | 17 |
News Archive
Sometimes cardiologists and cardiac surgeons can agree! There is often disagreement between the professions of cardiology and cardiac surgery about the proper therapy for coronary artery disease (CAD)-and this can harm the patient.
BioAlliance Pharma has attended the 49th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) in San Francisco to present results on miconazole Lauriad and anti-integrase inhibitor.
Thomas Vaughan, M.D., head of the Epidemiology Program in the Public Health Sciences Division of Fred Hutchinson Cancer Research Center, has received a three-year, $7.9 million grant from the National Cancer Institute to study genetic susceptibility for Barrett's esophagus and esophageal adenocarcinoma, a rapidly fatal cancer whose incidence has increased more than 500 percent in the past 30 years, faster than any other cancer in the United States.
HASCO Medical, Inc., a managed healthcare provider that serves patients in Alabama, Florida, and Mississippi, announced today its acquisition of Mobility Freedom Inc. and Wheelchair Vans of America.
Peregrine Pharmaceuticals, Inc. today announced financial results for the second quarter of fiscal year (FY) 2010 ended October 31, 2009. Total revenue for the second quarter of FY 2010 increased 255% to $6,896,000, compared to $1,941,000 for the comparable prior year quarter.
› Verified 3 days ago
| Entity Name | St Alexius Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1205868429 PECOS PAC ID: 8426960865 Enrollment ID: O20031104000146 |
News Archive
Sometimes cardiologists and cardiac surgeons can agree! There is often disagreement between the professions of cardiology and cardiac surgery about the proper therapy for coronary artery disease (CAD)-and this can harm the patient.
BioAlliance Pharma has attended the 49th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) in San Francisco to present results on miconazole Lauriad and anti-integrase inhibitor.
Thomas Vaughan, M.D., head of the Epidemiology Program in the Public Health Sciences Division of Fred Hutchinson Cancer Research Center, has received a three-year, $7.9 million grant from the National Cancer Institute to study genetic susceptibility for Barrett's esophagus and esophageal adenocarcinoma, a rapidly fatal cancer whose incidence has increased more than 500 percent in the past 30 years, faster than any other cancer in the United States.
HASCO Medical, Inc., a managed healthcare provider that serves patients in Alabama, Florida, and Mississippi, announced today its acquisition of Mobility Freedom Inc. and Wheelchair Vans of America.
Peregrine Pharmaceuticals, Inc. today announced financial results for the second quarter of fiscal year (FY) 2010 ended October 31, 2009. Total revenue for the second quarter of FY 2010 increased 255% to $6,896,000, compared to $1,941,000 for the comparable prior year quarter.
› Verified 3 days ago
| Entity Name | Mid Dakota Clinic, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1275587826 PECOS PAC ID: 9638072895 Enrollment ID: O20040127001063 |
News Archive
Sometimes cardiologists and cardiac surgeons can agree! There is often disagreement between the professions of cardiology and cardiac surgery about the proper therapy for coronary artery disease (CAD)-and this can harm the patient.
BioAlliance Pharma has attended the 49th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) in San Francisco to present results on miconazole Lauriad and anti-integrase inhibitor.
Thomas Vaughan, M.D., head of the Epidemiology Program in the Public Health Sciences Division of Fred Hutchinson Cancer Research Center, has received a three-year, $7.9 million grant from the National Cancer Institute to study genetic susceptibility for Barrett's esophagus and esophageal adenocarcinoma, a rapidly fatal cancer whose incidence has increased more than 500 percent in the past 30 years, faster than any other cancer in the United States.
HASCO Medical, Inc., a managed healthcare provider that serves patients in Alabama, Florida, and Mississippi, announced today its acquisition of Mobility Freedom Inc. and Wheelchair Vans of America.
Peregrine Pharmaceuticals, Inc. today announced financial results for the second quarter of fiscal year (FY) 2010 ended October 31, 2009. Total revenue for the second quarter of FY 2010 increased 255% to $6,896,000, compared to $1,941,000 for the comparable prior year quarter.
› Verified 3 days ago
| Entity Name | Innovis Health Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1215125463 PECOS PAC ID: 9931298155 Enrollment ID: O20071211000158 |
News Archive
Sometimes cardiologists and cardiac surgeons can agree! There is often disagreement between the professions of cardiology and cardiac surgery about the proper therapy for coronary artery disease (CAD)-and this can harm the patient.
BioAlliance Pharma has attended the 49th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) in San Francisco to present results on miconazole Lauriad and anti-integrase inhibitor.
Thomas Vaughan, M.D., head of the Epidemiology Program in the Public Health Sciences Division of Fred Hutchinson Cancer Research Center, has received a three-year, $7.9 million grant from the National Cancer Institute to study genetic susceptibility for Barrett's esophagus and esophageal adenocarcinoma, a rapidly fatal cancer whose incidence has increased more than 500 percent in the past 30 years, faster than any other cancer in the United States.
HASCO Medical, Inc., a managed healthcare provider that serves patients in Alabama, Florida, and Mississippi, announced today its acquisition of Mobility Freedom Inc. and Wheelchair Vans of America.
Peregrine Pharmaceuticals, Inc. today announced financial results for the second quarter of fiscal year (FY) 2010 ended October 31, 2009. Total revenue for the second quarter of FY 2010 increased 255% to $6,896,000, compared to $1,941,000 for the comparable prior year quarter.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jerry M Obritsch, MD 1000 E Rosser Ave, Bismarck, ND 58501-4414 Ph: (701) 712-4500 | Dr Jerry M Obritsch, MD 1000 E Rosser Ave, Bismarck, ND 58501-4414 Ph: (701) 712-4500 |
News Archive
Sometimes cardiologists and cardiac surgeons can agree! There is often disagreement between the professions of cardiology and cardiac surgery about the proper therapy for coronary artery disease (CAD)-and this can harm the patient.
BioAlliance Pharma has attended the 49th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) in San Francisco to present results on miconazole Lauriad and anti-integrase inhibitor.
Thomas Vaughan, M.D., head of the Epidemiology Program in the Public Health Sciences Division of Fred Hutchinson Cancer Research Center, has received a three-year, $7.9 million grant from the National Cancer Institute to study genetic susceptibility for Barrett's esophagus and esophageal adenocarcinoma, a rapidly fatal cancer whose incidence has increased more than 500 percent in the past 30 years, faster than any other cancer in the United States.
HASCO Medical, Inc., a managed healthcare provider that serves patients in Alabama, Florida, and Mississippi, announced today its acquisition of Mobility Freedom Inc. and Wheelchair Vans of America.
Peregrine Pharmaceuticals, Inc. today announced financial results for the second quarter of fiscal year (FY) 2010 ended October 31, 2009. Total revenue for the second quarter of FY 2010 increased 255% to $6,896,000, compared to $1,941,000 for the comparable prior year quarter.
› Verified 3 days ago
Rachel Marohl, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1000 E Rosser Ave, Bismarck, ND 58501 Phone: 701-712-4500 | |
Dr. Jessica D Sedevie, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 414 N 7th St, Bismarck, ND 58501 Phone: 701-323-5441 | |
Dr. Peter L Klemin, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 414 N. 7th St., Medcenter One, Inc., Bismarck, ND 58501 Phone: 701-323-5870 Fax: 701-323-5869 | |
Peter A.u. Woodrow, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 414 N 7th St, Bismarck, ND 58501 Phone: 701-323-6543 Fax: 701-323-5709 | |
Laura Elizabeth Knutson, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1000 E Rosser Ave, Bismarck, ND 58501 Phone: 701-712-4541 Fax: 701-712-4191 | |
Dr. Shannon S Bradley, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 310 N 10th St, Bismarck, ND 58501 Phone: 701-530-6000 Fax: 701-530-6430 |